JP2011177194A5 - - Google Patents

Download PDF

Info

Publication number
JP2011177194A5
JP2011177194A5 JP2011129778A JP2011129778A JP2011177194A5 JP 2011177194 A5 JP2011177194 A5 JP 2011177194A5 JP 2011129778 A JP2011129778 A JP 2011129778A JP 2011129778 A JP2011129778 A JP 2011129778A JP 2011177194 A5 JP2011177194 A5 JP 2011177194A5
Authority
JP
Japan
Prior art keywords
substance
fatigue
amount
candidate
human herpesvirus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011129778A
Other languages
English (en)
Japanese (ja)
Other versions
JP5542093B2 (ja
JP2011177194A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2011129778A priority Critical patent/JP5542093B2/ja
Priority claimed from JP2011129778A external-priority patent/JP5542093B2/ja
Publication of JP2011177194A publication Critical patent/JP2011177194A/ja
Publication of JP2011177194A5 publication Critical patent/JP2011177194A5/ja
Application granted granted Critical
Publication of JP5542093B2 publication Critical patent/JP5542093B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2011129778A 2004-07-14 2011-06-10 疲労度評価方法およびその利用 Expired - Lifetime JP5542093B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2011129778A JP5542093B2 (ja) 2004-07-14 2011-06-10 疲労度評価方法およびその利用

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2004235667 2004-07-14
JP2004235667 2004-07-14
JP2011129778A JP5542093B2 (ja) 2004-07-14 2011-06-10 疲労度評価方法およびその利用

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2007188969A Division JP4812708B2 (ja) 2004-07-14 2007-07-20 疲労度評価方法およびその利用

Publications (3)

Publication Number Publication Date
JP2011177194A JP2011177194A (ja) 2011-09-15
JP2011177194A5 true JP2011177194A5 (enExample) 2012-08-23
JP5542093B2 JP5542093B2 (ja) 2014-07-09

Family

ID=35783971

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2006529099A Expired - Fee Related JP4218842B2 (ja) 2004-07-14 2005-07-13 疲労度評価方法およびその利用
JP2011129778A Expired - Lifetime JP5542093B2 (ja) 2004-07-14 2011-06-10 疲労度評価方法およびその利用

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2006529099A Expired - Fee Related JP4218842B2 (ja) 2004-07-14 2005-07-13 疲労度評価方法およびその利用

Country Status (3)

Country Link
US (3) US7824888B2 (enExample)
JP (2) JP4218842B2 (enExample)
WO (1) WO2006006634A1 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7824888B2 (en) 2004-07-14 2010-11-02 Virus Ikagaku Kenkyusho Inc. Methods for assessing fatigue level and applications thereof
US8672843B2 (en) * 2006-11-27 2014-03-18 Qtc Management, Inc. Automated protocol for determining psychiatric disability
EP2199391B1 (en) 2007-09-27 2015-11-11 Japan Tobacco, Inc. Factor involved in latent infection with herpesvirus, and use thereof
CA2722952A1 (en) * 2008-03-31 2009-10-08 Japan Tobacco Inc. Quantitation method of virus
US9657324B1 (en) 2008-10-03 2017-05-23 Virus Ikagaku Kenkyusho Inc. Method for treating or preventing mood disorders
US20110313306A1 (en) * 2010-06-16 2011-12-22 Sociedad Europea de Analisis Diferencial de Movilidad Method and apparatus for monitoring stress levels or sudden changes of humor in humans or other individuals in real time by means of vapor analysis
US8812428B2 (en) 2010-09-20 2014-08-19 Pulsar Informatics, Inc. Systems and methods for assessment of fatigue-related contextual performance using historical incident data
US9030294B2 (en) 2010-09-20 2015-05-12 Pulsar Informatics, Inc. Systems and methods for collecting biometrically verified actigraphy data
US8568330B2 (en) 2011-03-08 2013-10-29 Pulsaw Informatics, Inc. Composite human physiological stress index based on heart beat and sleep and/or activity history data including actigraphy
US9002671B2 (en) 2011-04-29 2015-04-07 Pulsar Informatics, Inc. Systems and methods for latency and measurement uncertainty management in stimulus-response tests
NZ630770A (en) * 2013-10-09 2016-03-31 Resmed Sensor Technologies Ltd Fatigue monitoring and management system
JP6608818B2 (ja) 2014-06-27 2019-11-20 日本たばこ産業株式会社 気分障害を診断、治療又は予防する方法
US10539578B2 (en) 2015-12-28 2020-01-21 Japan Tobacco Inc. Method for diagnosing, treating, or preventing mood disorders
US12013365B2 (en) 2018-07-19 2024-06-18 Osaka University Virus measuring method, virus measuring device, virus determining program,stress determining method, and stress determining device

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5756281A (en) * 1991-05-23 1998-05-26 Martin; William John Stealth virus detection in the chronic fatigue syndrome
JPH1138004A (ja) 1997-07-16 1999-02-12 Pola Chem Ind Inc ストレスの定量法
JPH11304793A (ja) 1998-04-27 1999-11-05 Taisho Pharmaceut Co Ltd 抗精神疲労活性物質の評価方法
JP4123565B2 (ja) 1998-04-27 2008-07-23 大正製薬株式会社 抗精神疲労活性物質の評価方法
US7824888B2 (en) * 2004-07-14 2010-11-02 Virus Ikagaku Kenkyusho Inc. Methods for assessing fatigue level and applications thereof

Similar Documents

Publication Publication Date Title
JP2011177194A5 (enExample)
IN2014MN02060A (enExample)
RU2018101257A (ru) Способ детекции нуклеосом, содержащих гистоновые варианты
BR112014014960A2 (pt) métodos para o diagnóstico da doença de alzheimer
WO2011106536A3 (en) Methods of diagnosing infectious disease pathogens and their drug sensitivity
GB201121404D0 (en) Diagnosis
EP3206034A3 (en) Use of fatty acids in methods for detecting cancer
WO2013039477A8 (en) Non-invasive methods of detecting target molecules
EP2532748A3 (en) DNA aptamer specifically binding to human cardiac troponin I
WO2008091557A3 (en) Devices, systems, and methods to evaluate cardiovascular function
WO2009001545A1 (ja) 移植片対宿主疾患の検査および治療方法
EP2579043A4 (en) DETECTION METHOD
JP2013504766A5 (enExample)
JP2007330263A5 (enExample)
EP1981401A4 (en) MEASURE HEART MINUTES VOLUME AND BLOOD VOLUME BY NON-INVASIVE DETECTION OF INDICATOR DILUTION
WO2011027332A3 (en) Microrna expression signature in peripheral blood of patients affected by hepatocarcinoma or hepatic cirrhosis and uses thereof
WO2012008747A3 (ko) 피부 진단 방법 및 키트
WO2011109285A3 (en) Prognostic marker for cryoglobulinemic vasculitis and b cell malignancies in hcv infected patients
BR112013030646A2 (pt) uso diagnóstico de pró-somatostatina
EP2839281A4 (en) COMPOSITIONS AND METHODS OF IDENTIFYING AND DIAGNOSIS OF SALT SENSITIVITY OF BLOOD PRESSURE
Açıkgöz et al. Comparison of MDRD formula with creatinine clearance in estimation of glomerular filtration rate
WO2012178030A3 (en) Accurate measurement of glutathione for disease diagnosis and drug metabolite screening
CN106248921A8 (zh) 利用透明质酸评价肾损伤的方法和组合物
JP2015503106A5 (enExample)
WO2010140824A3 (ko) 간세포암의 진단 및 예후결정용 조성물